Free Trial

Salesforce (CRM) Stock Forecast & Price Target

Salesforce logo
$343.65 +7.42 (+2.21%)
(As of 12/20/2024 05:45 PM ET)

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
33

Based on 41 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 8 have given a hold rating, 29 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$378.86
10.25% Upside
According to the 41 analysts' twelve-month price targets for Salesforce, the average price target is $378.86. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted upside of 10.25% from the current price of $343.65.
Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

Sign Up

CRM Analyst Ratings Over Time

TypeCurrent Forecast
12/24/23 to 12/23/24
1 Month Ago
11/24/23 to 11/23/24
3 Months Ago
9/25/23 to 9/24/24
1 Year Ago
12/24/22 to 12/24/23
Strong Buy
4 Strong Buy rating(s)
4 Strong Buy rating(s)
3 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
29 Buy rating(s)
27 Buy rating(s)
26 Buy rating(s)
26 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
12 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$378.86$336.37$307.73$259.61
Forecasted Upside10.25% Upside-1.65% Downside13.79% Upside-2.53% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.90
2.69
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside10.25% Upside265.04% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent CRM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/18/2024Macquarie
1 of 5 stars
C. Beynon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$370.00 ➝ $370.00+5.50%
12/18/2024JMP Securities
2 of 5 stars
 Reiterated RatingMarket Outperform ➝ Market Outperform$450.00 ➝ $450.00+27.15%
12/18/2024Wedbush
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$425.00 ➝ $425.00+21.08%
12/18/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$405.00 ➝ $405.00+15.38%
12/18/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$375.00 ➝ $375.00+6.83%
12/13/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$440.00+22.84%
12/4/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$340.00 ➝ $360.00-2.16%
12/4/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$340.00 ➝ $380.00+3.28%
12/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$400.00 ➝ $425.00+15.51%
12/4/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$300.00 ➝ $420.00+16.53%
12/4/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$368.00 ➝ $390.00+7.93%
12/4/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Outperform ➝ Sector Outperform$425.00 ➝ $440.00+22.47%
12/4/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$315.00 ➝ $415.00+14.17%
12/4/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$360.00 ➝ $400.00+8.54%
12/4/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$385.00 ➝ $415.00+25.09%
12/4/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral
12/4/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$385.00 ➝ $425.00+28.10%
12/4/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$380.00 ➝ $400.00+20.57%
12/4/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$390.00 ➝ $425.00+28.10%
12/4/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$415.00 ➝ $425.00+28.10%
12/4/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$340.00 ➝ $430.00+29.61%
12/4/2024Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$400.00 ➝ $440.00+32.62%
12/4/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$390.00 ➝ $440.00+32.62%
12/4/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$330.00 ➝ $405.00+22.07%
12/3/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$250.00 ➝ $300.00-9.32%
11/22/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$275.00 ➝ $360.00+5.26%
11/21/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$290.00 ➝ $340.00+0.01%
11/19/2024Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
11/12/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$275.00 ➝ $330.00-4.35%
10/17/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aaron Siegel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$343.00+16.88%
10/2/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/30/2024Phillip Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Accumulate$305.00+20.72%
8/29/2024FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seyrafi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$234.00 ➝ $236.00-8.87%
8/29/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$335.00 ➝ $335.00+28.58%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$325.00 ➝ $350.00+35.19%
8/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+13.39%
5/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$350.00 ➝ $300.00+39.82%
5/30/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$345.00 ➝ $300.00+10.25%
Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

4/16/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$365.00+33.82%
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$290.00 ➝ $354.00+16.46%
9/15/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$267.00+22.04%
6/1/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Baldry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
6/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
3/2/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$140.00 ➝ $200.00+19.51%
2/21/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$160.00 ➝ $170.00+2.92%
1/20/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:48 AM ET.


Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

  • Salesforce, Inc. has shown strong revenue growth, reporting $9.44 billion for the latest quarter, exceeding analyst expectations of $9.35 billion. This indicates robust demand for its services.
  • The stock price recently increased to $354.85, reflecting a 1.7% rise, which may suggest positive market sentiment and potential for further appreciation.
  • Salesforce, Inc. maintains a healthy market capitalization of approximately $339.59 billion, indicating its strong position in the market and ability to invest in growth opportunities.
  • The company has a solid return on equity of 12.34%, which measures how effectively it uses equity investments to generate profits, making it an attractive option for investors seeking efficient management.
  • Institutional investors own 80.43% of Salesforce, Inc.'s stock, which often indicates confidence in the company's future performance and stability.

Salesforce
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

  • Salesforce, Inc. reported earnings per share (EPS) of $2.41, which missed analysts' consensus estimate of $2.44 by $0.03. This shortfall may raise concerns about the company's ability to meet future earnings expectations.
  • The company's price-to-earnings (P/E) ratio stands at 59.09, which is relatively high and may suggest that the stock is overvalued compared to its earnings, potentially limiting upside for new investors.
  • Despite recent revenue growth, the net margin of 15.96% indicates that a significant portion of revenue is consumed by expenses, which could affect profitability in the long run.
  • Salesforce, Inc. has a beta of 1.30, suggesting that its stock price is more volatile than the market. This could lead to higher risk for investors, especially in uncertain market conditions.
  • The company has a debt-to-equity ratio of 0.14, which is low, but any increase in debt levels could impact financial stability and investor confidence.

CRM Forecast - Frequently Asked Questions

According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $378.86, with a high forecast of $450.00 and a low forecast of $236.00.

41 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There are currently 8 hold ratings, 29 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 10.25% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 5 upgrades and 1 downgrade by analysts.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.90 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how CRM compares to other companies.


This page (NYSE:CRM) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners